SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

FLGT

Fulgent Genetics Inc.
NASDAQHealth Care

Latest close: 19.81 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 2, 2026Reported sale · Form 4Hanlin Gao, Chief Scientific Officer · $32.9KOpen the filing ↗
  2. Sep 2, 2026Reported sale · Form 4Jian Xie, President and COO · $41.8KOpen the filing ↗
  3. Sep 2, 2026Notice of sale · Form 144Xie Jian · Officer · $41.8KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record64615 flagged findings
Reported transactions (Form 4)52since Jan 3, 2023 · and 1 other holding
Corporate events (8-K)28since Apr 26, 2017

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

biotechnology company

Source: Wikidata (CC0 1.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-01capital return (buybacks/dividends)recentOpen filing ↗
    “…harm, among other factors. Item 1A. Risk Factors. There have been no material changes to the risk factors set forth in Part I, “…”
    +1 more passage from the same document
    • “…1A. Risk Factors. There have been no material changes to the risk factors set forth in Part I, “ Item 1A, Risk Factors, ” of the…”
  • 2026-05-01regulatory investigationrecentOpen filing ↗
    “…See Note 9, Leases , for further information. Contingencies From time to time, the Company may be subject to legal proceedings and…”
  • 2026-05-01Department of Justice inquiryrecentOpen filing ↗
    “…From time to time, the Company may be subject to legal proceedings and claims arising in the ordinary course of business. As…”
  • 2026-05-01merger or acquisition eventrecentOpen filing ↗
    “…the next two years. The contingent consideration is classified as equity, and the fair value of $ 5.7 million was calculated based…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 646)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Jul 30, 2610-Q ↗Quarterly report
  • Jul 30, 268-K ↗Current report · Results · Communication to the market
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 2, 26Form 144 ↗Notice of proposed sale
  • Jun 2, 268-K ↗Current report · Other events
  • Insider transaction · 2 Form 4 filingsshow all 2hide

646 filings on record, the oldest from Jul 7, 16.

Listing the 25 most recent filings of the 646 on record.

8-Ks, explained

Stress1Structure17Governance10
  • May 14, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 17, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Dec 22, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 18, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jan 12, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jan 3, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Nov 23, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Governance3 senior executive changes2022show all 3hide
    • Nov 4, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 29, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 30, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 26, 22StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Apr 18, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 29, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Feb 5, 21StructureEntered a material agreement8-K 1.01 ↗

12 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Ming Hsieh32.3%May 22, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Barclays PLC7.6%Mar 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • BlackRock, Inc.5.9%Mar 31, 25SCHEDULE 13G/A ↗
  • Millennium Management LLC5.6%Jul 22, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Ramya Rao5.4%Dec 31, 24SCHEDULE 13G ↗
  • Integrated Core Strategies (US) LLC3.0%Dec 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 2, Xie Jian filed notice of intent to sell up to $42K.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $42K on Sep 2, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+3 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 2, 26Sell$33KHanlin GaoChief Scientific Officer↗
  • Sep 2, 26Sell$42KJian XiePresident and COO↗
  • Aug 27, 26Sell$19KHanlin GaoChief Scientific Officer↗
  • Aug 27, 26Sell$24KJian XiePresident and COO↗
  • Jun 2, 26Sell$30KHanlin GaoChief Scientific Officer↗
  • Jun 2, 26Sell$38KJian XiePresident and COO↗
  • May 27, 26Sell$17KHanlin GaoChief Scientific Officer↗
  • May 27, 26Sell$21KJian XiePresident and COO↗
Stock compensation, tax and giftsshow the 32 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 1, 26Tax$41KPaul KimCFO and Treasurer↗
  • Sep 1, 26Tax$86KMing HsiehChief Executive Officer↗
  • Aug 26, 26Tax$23KPaul KimCFO and Treasurer↗
  • Aug 26, 26Tax$58KMing HsiehChief Executive Officer↗
  • Jul 26, 26Tax$32KHanlin GaoChief Scientific Officer↗
  • Jul 26, 26Tax$86KJian XiePresident and COO↗
  • Jul 26, 26Tax$54KPaul KimCFO and Treasurer↗
  • Jun 1, 26Tax$38KPaul KimCFO and Treasurer↗
  • Jun 1, 26Tax$79KMing HsiehChief Executive Officer↗
  • May 26, 26Tax$52KMing HsiehChief Executive Officer↗
  • May 26, 26Tax$21KPaul KimCFO and Treasurer↗
  • May 14, 26Compensationamount n/aREGINA E GROVES↗
  • May 14, 26Compensationamount n/aLinda Dong↗
  • May 14, 26Compensationamount n/aMichael Nohaile↗
  • Apr 26, 26Tax$45KPaul KimCFO and Treasurer↗
  • Apr 26, 26Tax$71KJian XiePresident and COO↗
  • Apr 26, 26Tax$27KHanlin GaoChief Scientific Officer↗
  • Mar 1, 26Tax$17KPaul KimCFO and Treasurer↗
  • Mar 1, 26Tax$128KPaul KimCFO and Treasurer↗
  • Mar 1, 26Tax$269KMing HsiehChief Executive Officer↗
  • Mar 1, 26Tax$16KHanlin GaoChief Scientific Officer↗
  • Mar 1, 26Tax$98KHanlin GaoChief Scientific Officer↗
  • Mar 1, 26Tax$17KJian XiePresident and COO↗
  • Mar 1, 26Tax$125KJian XiePresident and COO↗
  • Feb 26, 26Tax$29KPaul KimCFO and Treasurer↗
  • Feb 26, 26Tax$73KMing HsiehChief Executive Officer↗
  • Feb 26, 26Tax$22KHanlin GaoChief Scientific Officer↗
  • Feb 26, 26Tax$28KJian XiePresident and COO↗
  • Feb 24, 26Compensationamount n/aMing HsiehChief Executive Officer↗
  • Feb 24, 26Compensationamount n/aMing HsiehChief Executive Officer↗
  • Feb 24, 26Compensationamount n/aMing HsiehChief Executive Officer↗
  • Feb 24, 26Tax$236KMing HsiehChief Executive Officer↗

The full record holds 319 transactions and goes back to Mar 10, 21.

Its sector and its market

Fulgent Genetics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Fulgent Genetics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Fulgent Genetics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
646 documents on file, from Jul 7, 2016 to Sep 3, 2026.
Company description
Wikidata, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.